Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 19 Oct 20 424B4 Prospectus supplement with pricing info
- 16 Oct 20 EFFECT Notice of effectiveness
-
9 Oct 20 S-1/A IPO registration (amended)
- 25 Sep 20 S-1 IPO registration
ALGS similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated August 25, 2020 (except for the effects of the reverse stock split described in Note 1, as to which the date is October 9, 2020), in the Registration Statement (Form S-1) and related Prospectus of Aligos Therapeutics, Inc. for the registration of shares of its common stock.
/s/ Ernst & Young LLP
Redwood City, California
October 9, 2020